← Back to all signals
RESEARCH PAPER ANALYSIS

Choices of morbidity outcomes and concentration-response functions for health risk assessment of long-term exposure to air pollution.

AI interpretation is pending for this paper.

Open original publication →
PMID39045486
JournalEnvironmental epidemiology (Philadelphia, Pa.)
Publication Date2024-06-25
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Air pollution health risk assessment (HRA) has been typically conducted for all causes and cause-specific mortality based on concentration-response functions (CRFs) from meta-analyses that synthesize the evidence on air pollution health effects. There is a need for a similar systematic approach for HRA for morbidity outcomes, which have often been omitted from HRA of air pollution, thus underestimating the full air pollution burden. We aimed to compile from the existing systematic reviews and meta-analyses CRFs for the incidence of several diseases that could be applied in HRA. To achieve this goal, we have developed a comprehensive strategy for the appraisal of the systematic reviews and meta-analyses that examine the relationship between long-term exposure to particulate matter with an aerodynamic diameter smaller than 2.5 µm (PM2.5), nitrogen dioxide (NO2), or ozone (O3) and incidence of various diseases. METHODS: To establish the basis for our evaluation, we considered the causality determinations provided by the US Environmental Protection Agency Integrated Science Assessment for PM2.5, NO2, and O3. We developed a list of pollutant/outcome pairs based on these assessments and the evidence of a causal relationship between air pollutants and specific health outcomes. We conducted a comprehensive literature search using two databases and identified 75 relevant systematic reviews and meta-analyses for PM2.5 and NO2. We found no relevant reviews for long-term exposure to ozone. We evaluated the reliability of these studies using an adaptation of the AMSTAR 2 tool, which assesses various characteristics of the reviews, such as literature search, data extraction, statistical analysis, and bias evaluation. The tool's adaptation focused on issues relevant to studies on the health effects of air pollution. Based on our assessment, we selected reviews that could be credible sources of CRF for HRA. We also assessed the confidence in the findings of the selected systematic reviews and meta-analyses as the sources of CRF for HRA. We developed specific criteria for the evaluation, considering factors such as the number of included studies, their geographical distribution, heterogeneity of study results, the statistical significance and precision of the pooled risk estimate in the meta-analysis, and consistency with more recent studies. Based on our assessment, we classified the outcomes into three lists: list A (a reliable quantification of health effects is possible in an HRA), list B+ (HRA is possible, but there is greater uncertainty around the reliability of the CRF compared to those included on list A), and list B- (HRA is not recommended because of the substantial uncertainty of the CRF). RESULTS: In our final evaluation, list A includes six CRFs for PM2.5 (asthma in children, chronic obstructive pulmonary disease, ischemic heart disease events, stroke, hypertension, and lung cancer) and three outcomes for NO2 (asthma in children and in adults, and acute lower respiratory infections in children). Three additional outcomes (diabetes, dementia, and autism spectrum disorders) for PM2.5 were included in list B+. Recommended CRFs are related to the incidence (onset) of the diseases. The International Classification of Diseases, 10th revision codes, age ranges, and suggested concentration ranges are also specified to ensure consistency and applicability in an HRA. No specific suggestions were given for ozone because of the lack of relevant systematic reviews. CONCLUSION: The suggestions formulated in this study, including CRFs selected from the available systematic reviews, can assist in conducting reliable HRAs and contribute to evidence-based decision-making in public health and environmental policy. Future research should continue to update and refine these suggestions as new evidence becomes available and methodologies evolve.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 [Allogeneic hematopoietic stem cell transplantation for 510 patients with active relapsed/refractory acute myeloid leukemia: a real-world study]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 70.74 2 [Clinical characteristics and prognosis of acute myeloid leukemia patients with RUNX1 single-site and multiple-site gene mutations]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 73.4 3 Lymphoma presenting as a genitourinary lesion in children: A case series highlighting diagnostic challenges and the risk of unnecessary organ resection. Journal of pediatric urology 73.8 4 Posterior Reversible Encephalopathy Syndrome (PRES) in an Anuric Patient With a WT1 Mutation and Chronic Renal Graft Failure: A Case Report. Cureus 52.7 5 Gestational hypercalcemia: a narrative review of literature. Frontiers in medicine 60.9 6 [Surgical designs and clinical effects of pedicled transfer of extended lower trapezius musculocutaneous flap in repairing massive wounds in the shoulder and back]. Zhonghua shao shang yu chuang mian xiu fu za zhi 57.7 7 Identification of the Characteristics and Prognostic Impact of t(3;5)(q25;q35)/NPM1::MLF1 Fusion Genes and NPM1 Mutations in Acute Myeloid Leukemia Patients. Clinical lymphoma, myeloma & leukemia 63.9 8 Oral bacteriome in pediatric patients with malignancies prior to chemotherapy: a pilot study using full-length 16S rRNA sequencing. Frontiers in cellular and infection microbiology 65.44 9 hNET-targeted [18F]MFBG PET as baseline functional imaging in newly diagnosed neuroblastoma. Theranostics 64.3 10 [Clinical analysis of 26 littoral cell angioma of the spleen cases]. Zhonghua yi xue za zhi 61.6 11 An Art Therapy Workbook for Pediatric Patients with Cancer Receiving Palliative Care: Program Design and Effects. Journal of hospice and palliative care 62.24 12 Population-Level Trends in Gastric Cancer Mortality and Incidence After Expansion of Japanese National Health Insurance Coverage for Helicobacter pylori Eradication: A Descriptive Time-Trend Study. Helicobacter 64.3 13 Blinatumomab Care Delivery for Pediatric B-Cell Acute Lymphoblastic Leukemia. JAMA network open 78.6 14 From Innocence to Endurance: A Patient's Perspective on Lifelong Transplant Care. Journal of cardiac failure 54.0 15 Psychosocial interventions for reducing pain and pain-related distress in infants, children, and adolescents undergoing cancer treatment: a systematic review and meta-analysis of randomized control trials. Pain 70.94 16 Current status and influencing factors of fertility preservation decisional conflict among female cancer patients of childbearing age: A scoping review. European journal of oncology nursing : the official journal of European Oncology Nursing Society 74.4 17 Identification of the Genomic Etiology of Unexplained Congenital Problems in Pediatric Patients: First Reported Case With Coffin-Siris Syndrome and Sialuria From India. Clinical case reports 47.5 18 Integrated expression profiling of BCR-ABL and computational identification of ABL1 inhibitors in pediatric acute lymphoblastic leukemia. In silico pharmacology 68.46 19 Deep Learning Pipeline for Automatic Segmentation, Classification, and Molecular Subtyping of Three Pediatric Posterior Fossa Tumors Using T2-Weighted MRI. Journal of magnetic resonance imaging : JMRI 66.9 20 Reduced-dose Radiotherapy without Chemotherapy for Intracranial Germinomas: Results from an Asian Multicenter Study. Neuro-oncology 90.06 21 Pulmonary function in young childhood cancer survivors: results from a prospective multicentre cohort. ERJ open research 67.5 22 Differential in vivo tyrosine kinase inhibitor sensitivities of pediatric ABL-class Ph-like B-acute lymphoblastic leukemia. HemaSphere 49.66 23 Cryptic and Overt Acute Kidney Injury Share Biomarker Characteristics in Pediatric Acute Respiratory Distress Syndrome. Critical care explorations 57.35 24 [Proliferative nodule within a giant congenital melanocytic nevus: report of a case]. Zhonghua bing li xue za zhi = Chinese journal of pathology 28.5 25 Fertility preservation in women with central nervous system tumors. Expert review of anticancer therapy 79.2 26 Molecular profiling of pediatric medulloblastoma in Kazakhstan: Genomic alterations, subgroup distribution, and survival. Brain pathology (Zurich, Switzerland) 61.12 27 Association of a Child's Rare Disease Neurofibromatosis 1 with Parental Income and Employment Trajectories Following the Child's Birth. Genetics in medicine : official journal of the American College of Medical Genetics 61.0 28 Clinical Outcomes of Younger Adults With Philadelphia-Negative Acute Lymphoblastic Leukemia, Treated With A Pediatric-Like Regimen Based on the GIMEMA LAL1308 Protocol. A Campus ALL Study. European journal of haematology 84.6 29 Adnexal torsion due to teratoma in a young adolescent. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 56.0 30 Methylation profiling in CNS tumor diagnostics: a single-centre real-world experience from Central Europe. Virchows Archiv : an international journal of pathology 57.5 31 Pancreatic stent and transpapillary pseudocyst drainage via endoscopic retrograde cholangiopancreatography for children with blunt pancreatic duct injury. European journal of trauma and emergency surgery : official publication of the European Trauma Society 58.4 32 Geospatial assessment of groundwater quality, heavy metal contamination and human health risks in the rapidly industrializing and agriculturally dominated Shivalik Himalaya, India. Environmental geochemistry and health 59.9
PATIENT-FRIENDLY SUMMARY

Choices of morbidity outcomes and concentration-response functions for health risk assessment of long-term exposure to air pollution.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic